Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-001597

Director sold 29,350 shares at an average $87.49 ($2,567,754)

  • Director acquired 29,350 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-05 Exercise or conversion : show line 1 in the form 10b5-1 +29,350 $36.75 $1,078,613 33,835.82 D
2024-02-05 Sale : show line 2 in the form 10b5-1 −1,000 $89.61 $89,610 32,835.82 D
2024-02-05 Sale : show line 3 in the form 10b5-1 −6,422 $88.63 $569,182 26,413.82 D
2024-02-05 Sale : show line 4 in the form 10b5-1 −9,761 $86.44 $843,741 16,652.82 D
2024-02-05 Sale : show line 5 in the form 10b5-1 −12,167 $87.55 $1,065,221 4,485.82 D
Open-market sales · 29,350 sh · avg $87.49 · $2,567,754

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-02-05 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Acquire) −29,350 $36.75 2024-05-10 29,350 88,050 D
Loading xslF345X05/doc4.xml…